Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha (PIP5K1A) is a lipid kinase that phosphorylates phosphatidylinositol-4-phosphate (PI4P) to produce phosphatidylinositol 4,5-bisphosphate (PIP2), a key signaling lipid involved in a wide range of cellular processes, including signal transduction, cytoskeletal regulation, membrane trafficking, and cell proliferation. PIP5K1A activity is necessary for proper focal adhesion assembly, actin cytoskeleton organization, and is implicated in multiple signaling pathways such as Wnt. Structurally, PIP5K1A is a dimeric enzyme with a fold similar to that of protein kinases, and it requires dimerization for full activity. Dysregulation or overexpression of PIP5K1A is associated with cancers (including prostate cancer and glioma), neurological disorders, and increased cancer cell proliferation and survival
Inhibition of kinase activity would reduce cellular PIP2 synthesis and downstream signaling Modulation disrupts actin cytoskeleton and cell migration
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha (PIP5K1A).